Axon Enterprise Issues $1.15B 0% Convertible Notes Due 2031
$AXON · AXON ENTERPRISE, INC.Research Summary
AI-generated summary of this SEC filing
Axon Enterprise Issues $1.15B 0% Convertible Notes Due 2031
What Happened
Axon Enterprise, Inc. announced the issuance and sale of $1,150.0 million aggregate principal amount of 0% Convertible Senior Notes due 2031 (the “Notes”) and related capped‑call transactions. The offering closed on September 18, 2026 after underwriters exercised their full $150.0 million over‑allotment. The Notes pay no regular interest, mature September 15, 2031, and are convertible into common stock (or cash or a mix) subject to the terms in the indenture. The company also entered into capped‑call transactions to reduce potential dilution; the capped calls cost approximately $114.9 million.
Key Details
- Offering size: $1,150.0 million principal amount of 0% Convertible Senior Notes; $150.0 million sold via underwriter over‑allotment. Offering closed Sep 18, 2026.
- Conversion terms: initial conversion rate 1.5336 shares per $1,000 principal (≈ $652.06 conversion price per share); conversion settlement at Axon’s option (cash, stock or combo).
- Capped calls: entered concurrently; cost ≈ $114.9 million; initial cap price $1,049.94 per share (≈137.5% premium to $442.08 last sale on Sep 15, 2026). Company intends to use ~ $114.9M of net proceeds to pay for these capped calls; remainder for general corporate purposes.
- Key economics and rights: no regular interest or accretion; optional redemption possible (e.g., if stock ≥130% of conversion price for specified periods starting Sep 20, 2029); holder repurchase option around Mar 20, 2031; repurchase on Fundamental Change in certain cases. Notes are unsecured, senior to subordinated debt, junior to secured debt, and structurally junior to subsidiaries’ liabilities.
- Credit agreement: a second amendment to Axon’s credit agreement became effective upon closing of the Notes offering (as previously disclosed).
Why It Matters
This transaction raises $1.15 billion of convertible debt, providing Axon with significant capital for general corporate purposes (including growth and potential acquisitions) while limiting near‑term cash interest costs because the Notes bear no regular interest. The capped‑call hedges and conversion mechanics affect potential dilution and how conversions would be settled (cash vs. shares), which matters to shareholders assessing dilution risk. Redemption and conversion triggers, along with the Notes’ ranking and the credit‑agreement amendment, are key terms investors should review to understand debt priority, potential stock dilution, and refinancing or liquidity implications through 2031.